FDA Final Guidance; Pediatric Uses of Devices

From the Center for Devices and Radiological Health, Food and Drug Administration:

Today, the Food and Drug Administration (FDA) issued a final rule that requires manufactures to submit publicly available information on pediatric patients (21 years or younger) that suffer from the disease or condition that the devices submitted for FDA approval are intended to treat, diagnose, or cure. This information will help key stakeholders, device manufacturers, and the FDA identify what devices are available to pediatric patients and identify unmet pediatric device needs. Once unmet needs are identified, device manufacturers and FDA staff can use this information to promote new device development and proper labeling of existing medical devices for pediatric use.

Under the final rule, any request for a humanitarian device exemption (HDE), premarket approval application (PMA), supplement to a PMA, or product development protocol (PDP) must include readily available pediatric use information. Providing the FDA with this information will not require additional clinical research or other costly efforts. It simply requires the applicant to briefly summarize readily available information that may have already been reviewed during the course of the development of the device and preparation of the medical device application submitted to the FDA.

The FDA is working to finalize the draft guidance that was published on February 19, 2013 and does not anticipate major changes from draft to final guidance.   The final guidance will help manufactures understand and comply with the rule and discuss the following topics:

the types of medical device applications that must include the pediatric device use information;

a description of the specific pediatric device use information required to comply with the law;

what is meant by “readily available information”; • where to include the pediatric device use information within an application;

definitions of the pediatric patient population and of pediatric subpopulations;

how to provide the pediatric device use information within the application; • examples of acceptable sources that could address the pediatric use information requirement; and

what FDA will do with the submitted pediatric device use information.



Join over 6000 medical device professionals who receive our engineering, regulatory and commercialization insights and tips every month.